Annual CAPEX:
$6.19M-$2.65M(-30.02%)Summary
- As of today, PACB annual capital expenditures is $6.19 million, with the most recent change of -$2.65 million (-30.02%) on December 31, 2024.
- During the last 3 years, PACB annual CAPEX has risen by +$257.00 thousand (+4.33%).
- PACB annual CAPEX is now -63.45% below its all-time high of $16.93 million, reached on December 31, 2022.
Performance
PACB CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CAPEX:
N/ASummary
- PACB quarterly capital expenditures is not available.
Performance
PACB Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
TTM CAPEX:
N/ASummary
- PACB TTM capital expenditures is not available.
Performance
PACB TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
PACB CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -30.0% | - | - |
| 3Y3 Years | +4.3% | - | - |
| 5Y5 Years | +118.2% | - | - |
PACB CAPEX Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -63.5% | +4.3% | ||||
| 5Y | 5-Year | -63.5% | +495.6% | ||||
| All-Time | All-Time | -63.5% | +580.8% |
PACB CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $550.00K(-91.4%) | $9.34M(-9.0%) |
| Mar 2025 | - | $6.39M(+295.1%) | $10.27M(+32.3%) |
| Dec 2024 | $6.19M(-30.0%) | $1.62M(+105.5%) | $7.76M(-5.0%) |
| Sep 2024 | - | $787.00K(-46.8%) | $8.17M(-0.5%) |
| Jun 2024 | - | $1.48M(-61.9%) | $8.21M(-8.8%) |
| Mar 2024 | - | $3.88M(+91.7%) | $9.00M(+1.8%) |
| Dec 2023 | $8.84M(-47.8%) | $2.02M(+143.9%) | $8.84M(-25.7%) |
| Sep 2023 | - | $830.00K(-63.4%) | $11.90M(-22.0%) |
| Jun 2023 | - | $2.27M(-39.0%) | $15.26M(-10.3%) |
| Mar 2023 | - | $3.72M(-26.8%) | $17.01M(+0.5%) |
| Dec 2022 | $16.93M(+185.4%) | $5.08M(+21.3%) | $16.93M(+15.3%) |
| Sep 2022 | - | $4.19M(+4.2%) | $14.69M(+26.4%) |
| Jun 2022 | - | $4.02M(+10.5%) | $11.62M(+26.7%) |
| Mar 2022 | - | $3.64M(+28.0%) | $9.17M(+54.6%) |
| Dec 2021 | $5.93M(+470.8%) | $2.84M(+154.0%) | $5.93M(+87.9%) |
| Sep 2021 | - | $1.12M(-28.7%) | $3.16M(+22.7%) |
| Jun 2021 | - | $1.57M(+291.3%) | $2.57M(+94.5%) |
| Mar 2021 | - | $401.00K(+498.5%) | $1.32M(+27.3%) |
| Dec 2020 | $1.04M(-63.4%) | $67.00K(-87.5%) | $1.04M(-6.6%) |
| Sep 2020 | - | $536.00K(+68.0%) | $1.11M(-20.8%) |
| Jun 2020 | - | $319.00K(+172.6%) | $1.41M(-17.3%) |
| Mar 2020 | - | $117.00K(-17.0%) | $1.70M(-40.1%) |
| Dec 2019 | $2.84M(+53.0%) | $141.00K(-83.0%) | $2.84M(+3.0%) |
| Sep 2019 | - | $829.00K(+35.2%) | $2.75M(+36.3%) |
| Jun 2019 | - | $613.00K(-51.1%) | $2.02M(-26.9%) |
| Mar 2019 | - | $1.25M(+2060.3%) | $2.76M(+49.0%) |
| Dec 2018 | $1.85M(-82.2%) | $58.00K(-39.6%) | $1.85M(-35.1%) |
| Sep 2018 | - | $96.00K(-92.9%) | $2.86M(-52.5%) |
| Jun 2018 | - | $1.36M(+294.2%) | $6.02M(-25.8%) |
| Mar 2018 | - | $344.00K(-67.5%) | $8.11M(-22.3%) |
| Dec 2017 | $10.43M | $1.06M(-67.5%) | $10.43M(-13.2%) |
| Sep 2017 | - | $3.26M(-5.5%) | $12.02M(+8.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2017 | - | $3.45M(+29.2%) | $11.07M(+6.2%) |
| Mar 2017 | - | $2.67M(+0.6%) | $10.42M(+26.9%) |
| Dec 2016 | $8.21M(+172.7%) | $2.65M(+15.2%) | $8.21M(+27.6%) |
| Sep 2016 | - | $2.30M(-17.8%) | $6.43M(+40.1%) |
| Jun 2016 | - | $2.80M(+512.3%) | $4.59M(+67.0%) |
| Mar 2016 | - | $457.00K(-47.9%) | $2.75M(-8.6%) |
| Dec 2015 | $3.01M(+87.0%) | $878.00K(+91.3%) | $3.01M(+15.4%) |
| Sep 2015 | - | $459.00K(-51.9%) | $2.61M(+11.5%) |
| Jun 2015 | - | $955.00K(+33.2%) | $2.34M(+26.5%) |
| Mar 2015 | - | $717.00K(+50.3%) | $1.85M(+14.9%) |
| Dec 2014 | $1.61M(+77.0%) | $477.00K(+151.1%) | $1.61M(+30.4%) |
| Sep 2014 | - | $190.00K(-59.1%) | $1.23M(-3.1%) |
| Jun 2014 | - | $465.00K(-2.5%) | $1.27M(+17.0%) |
| Mar 2014 | - | $477.00K(+367.6%) | $1.09M(+19.8%) |
| Dec 2013 | $909.00K(-46.6%) | $102.00K(-55.7%) | $909.00K(-27.1%) |
| Sep 2013 | - | $230.00K(-17.9%) | $1.25M(-16.8%) |
| Jun 2013 | - | $280.00K(-5.7%) | $1.50M(-13.2%) |
| Mar 2013 | - | $297.00K(-32.5%) | $1.73M(+1.4%) |
| Dec 2012 | $1.70M(-81.7%) | $440.00K(-8.7%) | $1.70M(-36.9%) |
| Sep 2012 | - | $482.00K(-4.9%) | $2.70M(-39.7%) |
| Jun 2012 | - | $507.00K(+85.0%) | $4.48M(-44.5%) |
| Mar 2012 | - | $274.00K(-80.9%) | $8.06M(-13.2%) |
| Dec 2011 | $9.28M(+76.5%) | $1.44M(-36.3%) | $9.28M(+2.3%) |
| Sep 2011 | - | $2.26M(-44.8%) | $9.07M(+15.5%) |
| Jun 2011 | - | $4.09M(+173.5%) | $7.86M(+41.2%) |
| Mar 2011 | - | $1.50M(+21.7%) | $5.56M(+5.8%) |
| Dec 2010 | $5.26M(+1.6%) | $1.23M(+18.4%) | $5.26M(+30.5%) |
| Sep 2010 | - | $1.04M(-42.3%) | $4.03M(+34.7%) |
| Jun 2010 | - | $1.80M(+50.8%) | $2.99M(+150.8%) |
| Mar 2010 | - | $1.19M | $1.19M |
| Dec 2009 | $5.18M(-9.2%) | - | - |
| Dec 2008 | $5.70M(+87.1%) | - | - |
| Dec 2007 | $3.05M | - | - |
FAQ
- What is Pacific Biosciences of California, Inc. annual capital expenditures?
- What is the all-time high annual CAPEX for Pacific Biosciences of California, Inc.?
- What is Pacific Biosciences of California, Inc. annual CAPEX year-on-year change?
- What is the all-time high quarterly CAPEX for Pacific Biosciences of California, Inc.?
- What is the all-time high TTM CAPEX for Pacific Biosciences of California, Inc.?
What is Pacific Biosciences of California, Inc. annual capital expenditures?
The current annual CAPEX of PACB is $6.19M
What is the all-time high annual CAPEX for Pacific Biosciences of California, Inc.?
Pacific Biosciences of California, Inc. all-time high annual capital expenditures is $16.93M
What is Pacific Biosciences of California, Inc. annual CAPEX year-on-year change?
Over the past year, PACB annual capital expenditures has changed by -$2.65M (-30.02%)
What is the all-time high quarterly CAPEX for Pacific Biosciences of California, Inc.?
Pacific Biosciences of California, Inc. all-time high quarterly capital expenditures is $6.39M
What is the all-time high TTM CAPEX for Pacific Biosciences of California, Inc.?
Pacific Biosciences of California, Inc. all-time high TTM capital expenditures is $17.01M